Stock Events

Stock Events

Viracta Therapeutics (VIRX) Q4 2024 Earnings

13NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.37

-0.32

-0.28

-0.23

Details

Expected EPS

-0.266667

Actual EPS

-0.27

Surprise EPS

-0

Surprise Percent

+1.25%

Description

Viracta Therapeutics (VIRX) has reported earnings of -0.27 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.